Solvay

About: Solvay is a company organization based out in Brussels, Belgium. It is known for research contribution in the topics: Catalysis & Polymer. The organization has 6083 authors who have published 7004 publications receiving 105745 citations.

Aerobic Oxidation of Glucose to Glucaric Acid under Alkaline-Free Conditions: Au-Based Bimetallic Catalysts and the Effect of Residues in a Hemicellulose Hydrolysate

Abstract: Au–Pt and Au–Pd bimetallic catalysts were prepared over various supports using different preparation methods and were compared in the base-free selective aerobic catalytic oxidation of glucose to glucaric acid. The method of preparation of the bimetallic catalysts, the support material for the Au–Pt bimetallic nanoparticles, and the metal molar ratios have a strong influence on the activity and the maximum yield of glucaric acid. The Au–Pt/ZrO2 catalyst with a molar ratio for Au/Pt = 1 provides a 50% yield of glucaric acid at complete conversion of glucose and gluconic acid at 100 °C, under 40 bar air, using a glucose/metal ratio of 80. The catalyst was stable upon sequential recycling in a batch reactor and in long-term use in a continuous reactor. The influence of possible residual impurities has been studied. Furan derivatives or lignin residues might be problematic for catalytic oxidation of glucose in hemicellulose hydrolysates.

Prevalence of hypertension in the adult population of Belgium: report of a worksite study, Attention Hypertension

Abstract: Hypertension remains a major cause of cardiovascular morbidity in Belgium. Information on the prevalence of hypertension in the working population is desirable. A worksite study of hypertension prevalence was carried out in Belgium where 3472 individuals were screened for 1 week. The result was that high blood pressure (≥140/90 mm Hg) was identified in approximately one-third of the men and one-quarter of the women even though the majority of subjects had no recorded history of hypertension. Associations were identified between age and systolic blood pressure and, in men, between systolic blood pressure and alcohol consumption. Most participants in the survey were unaware of their serum cholesterol level. The results of this survey suggest that a large proportion of subjects with high blood pressure in the Belgian working population remain unidentified and indicate a lack of awareness about other cardiovascular risk factors.

Effect of a second, booster, influenza vaccination on antibody responses in quiescent systemic lupus erythematosus: an open, prospective, controlled study

Abstract: Objective. In SLE, a decreased antibody response on influenza vaccination has been reported. In this study, we assessed whether a booster vaccination could improve antibody responses, as determined by seroprotection rates, in SLE patients. Methods. SLE patients (n ¼ 52) with quiescent disease (SLEDAI 44) and healthy controls (HCs) (n ¼ 28) received subunit influenza vaccine in October–December 2007. After 4 weeks, only SLE patients received a second dose of vaccination. Sera were obtained before both vaccinations, and 4 weeks after the second vaccination. At each visit, SLE disease activity was recorded. The haemagglutination inhibition test was used to measure antibody titres. Seroprotection was defined as a titre 540. Results. Following the first vaccination, seroprotection rates and geometric mean titres (GMTs) to each vaccine strain increased in both SLE patients and controls to comparable levels. Seroprotection rates in SLE patients after the first vaccination were 86.5% to A/H1N1, 80.8% to A/H3N2 and 61.5% to the B-strain while GMTs were 92.6, 56.2 and 39.2, respectively. Overall, the booster vaccination did not lead to a further rise of seroprotection rates and GMTs in SLE patients. However, in patients not vaccinated in the previous year, GMT and seroconversion rate to A/H1N1 did rise following the booster vaccination. Both influenza vaccinations did not increase SLEDAI scores. Conclusions. Additional value of a booster influenza vaccination in SLE is limited to patients who were not vaccinated in the previous year.